silybin has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bornman, L; Cronjé, L; Edmondson, N; Eisenach, KD | 1 |
| Amirghofran, Z; Gharagozloo, M; Khoshdel, Z | 1 |
3 other study(ies) available for silybin and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions.
Topics: Base Sequence; Cell Survival; Deferoxamine; DNA, Bacterial; Humans; Iron; Iron Chelating Agents; Macrophages; Monocytes; Mycobacterium tuberculosis; Silybin; Silymarin; U937 Cells | 2005 |
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Deferoxamine; DNA Replication; Dose-Response Relationship, Drug; Humans; Iron; Iron Chelating Agents; Jurkat Cells; Leukemia, T-Cell; Silybin; Silymarin; Time Factors | 2008 |